Key points are not available for this paper at this time.
In this issue, Robbins et al describe three cases of endocarditis due toStreptococcus mutans, one of the viridans streptococci (p 1171). They emphasize that, as withS bovis(a nonenterococcal group D streptococcus),S mutanscan easily be mistaken for an enterococcus if the appropriate laboratory tests are not performed.Streptococcus mutansandS bovisare more susceptible to lower concentrations of multiple antibiotics, including penicillin, than are the enterococci.Streptococcus bovisendocarditis has been successfully treated with penicillin alone; however, Robbin's report represents the first published case ofS mutansendocarditis treated in this manner. Many authors recommend treating endocarditis caused by streptococci that have a minimum inhibitory concentration (MIC) against penicillin of 0.2 μg/ml or less with penicillin alone. The more resistant viridans organisms and the enterococci require an aminoglycoside in addition to penicillin for effective therapy. However, other authors recommend the addition of an aminoglycoside to
William L. Hoppes (Thu,) studied this question.